Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

479
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
479
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

328
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
328
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

710
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
710

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention for Stable Multivessel Coronary Disease in the Current Era.

The Annals of thoracic surgery·2026
Same author

Bioprosthetic versus mechanical surgical aortic valve replacement in patients ≥65 years of age.

JTCVS open·2026
Same author

Temporizing Balloon Aortic Valvuloplasty Before Transcatheter Aortic Valve Replacement in Decompensated Severe Aortic Stenosis.

The American journal of cardiology·2026
Same author

A 'Target Trial Emulation' of Prehospital Sublingual Nitroglycerin Administration for Suspected Acute Coronary Syndrome.

Prehospital emergency care·2026
Same author

Genetic Syndromes Do Not Affect Survival but Increase Morbidity in Neonates with Symptomatic Tetralogy of Fallot.

The Journal of pediatrics·2026
Same author

Unveiling the Potential of <i>N</i>-Hydroxyphthalimide with Zn in Alkylative Dearomatization of <i>N</i>-Alkylpyridinium Salts.

The Journal of organic chemistry·2026

相关实验视频

Updated: Feb 20, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

630

年轻人穿过导管的大动脉植入:转移风险和结果

J Hunter Mehaffey1, Vikrant Jagadeesan2, Michael Bowdish3

  • 1Department of Cardiovascular and Thoracic Surgery, West Virginia University.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
|February 18, 2026
PubMed
概括

接受过导管大动脉植入术 (TAVI) 的年轻患者 (≤65岁) 通常具有较低的手术风险. 对这些患者来说,仔细的心脏团队评估对于这些患者来说至关重要,考虑到TAVI.

关键词:
结果的结果.风险 风险 风险 风险 风险塔维 (TAVI) 是一个古老的城市.年轻的年轻的年轻的年轻人年轻的年轻人

更多相关视频

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.5K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.3K

相关实验视频

Last Updated: Feb 20, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

630
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.5K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.3K

科学领域:

  • 心血管医学 心血管医学
  • 干预心脏病学 干预心脏病学
  • 医疗保健服务研究 医疗服务研究

背景情况:

  • 透气管大动脉植入 (TAVI) 越来越多地用于65岁及以下的患者.
  • 这些年轻的患者往往被认为具有高手术风险,预期寿命有限.

研究的目的:

  • 为了评估预测的风险,程序结果,纵向结果和65岁或更年轻的患者TAVI的成本.
  • 在这个人口群体中基于预测的死亡风险对TAVI结果进行分层.

主要方法:

  • 对6,921名年龄在65岁或以下的患者进行分析,这些患者在2017年至2024年期间接受了TAVI.
  • 利用模拟的胸部外科医生协会风险模型,结合Fried脆弱指数来评估预测的死亡风险 (AUC=0.850).

主要成果:

  • 平均年龄为60岁,81.3%的手术是可选的,9.1%涉及双主动脉.
  • 平均预测死亡风险为4.3%,其中66.2%的患者的预测风险低于4%.
  • 30天死亡率为0.7%,显著的并发症率包括中风 (1.0%) 和新的永久起器 (4.1%). 低/中等风险患者的5年生存率为88%,高风险患者为78%.

结论:

  • 大多数65岁或更年轻的当代患者在当前指导方针之外接受TAVI治疗,手术风险较低.
  • 这些发现强调了对接受大动脉置换 (AVR) 的年轻患者进行彻底的心脏团队讨论的必要性,考虑到TAVI的累积风险.